Together, our results demonstrate that an IL-17A-expressing TNBC tumor microenvironment stimulates robust cytokine responses, particularly G-CSF production, in tumor-bearing hosts and promotes primary tumor growth and metastasis that are associated with the features consistent with immune suppression. This evidence concerns the gene IL17A and neoplasm.